Tipco Engineering, Speciality Medicines, and Sai Parenterals Announce March 2026 IPOs

Bias Analysis: The articles primarily present factual corporate announcements without political framing. Coverage focuses on business and financial details, reflecting a neutral economic perspective. There is no evident political bias, as the sources report on IPO plans, fund utilization, and market listings without partisan commentary or ideological positioning.

Sentiment: The overall tone across the articles is neutral to positive, emphasizing growth prospects and capital raising efforts. The language highlights company plans and financial strategies without criticism or controversy. Sentiment is generally optimistic about business expansion but remains factual and restrained, avoiding hype or negative assessments.

Lens Score: 32/100 — Story is well-covered by media outlets. Public interest: 0/100. Coverage gap: 90%.